Response to “From screening to clinical utility: Validating autoimmune‐associated epilepsy algorithms without antibody confirmation”
- 9 November 2026
- journal article
- Published by Wiley in Epileptic Disorders
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Pragmatic screening for autoimmune‐associated epilepsy in drug‐resistant epilepsy of unknown etiology in resource‐limited settings: A hypothesis‐generating studyEpileptic Disorders, 2026
- Diagnostic utility of cerebrospinal fluid (CSF) findings in seizures and epilepsy with and without autoimmune-associated diseaseSeizure: European Journal of Epilepsy, 2021
- Antibodies Contributing to Focal Epilepsy Signs and Symptoms ScoreAnnals of Neurology, 2021
- Hippocampus and Insula Are Targets in Epileptic Patients With Glutamic Acid Decarboxylase AntibodiesFrontiers in Neurology, 2019
- Predictors of neural-specific autoantibodies and immunotherapy response in patients with cognitive dysfunctionJournal of Neuroimmunology, 2018